CClinicalTrials.gg
CompletedNCT05727293Updated May 30, 2023

A Case Report of a Patient With Intellectual Disability and Neurogenic Bladder Complicated With Sepsis

An observational study in Sepsis Bacterial, sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Completed at 1 site in China. Open to male participants. Per ClinicalTrials.gov, last updated 2023-05-30.

Sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
1
Sex
Male
01

Study summary

A case report of a patient with intellectual disability and neurogenic bladder complicated with sepsis

Read the detailed description

To summarize the individual care experience of a patient with neurogenic cystitis with sepsis and mental retardation. The main points of nursing care include: conducting personalized nuring care for early sepsis; carring out care for urinary incontinence and urinary tract infection; bulinding health-management plans with family members; and a full course of psychologic diversion that alleviates negative feelings among patients and family members.

02

Conditions studied

  • Sepsis Bacterial

Keywords

  • intellectual disability;Neurogenic bladder;Sepsis ;
03

In context

Sepsis

1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.

This study's enrollment of 1 is below the median of 160 across 931 observational studies indexed under Sepsis.

Browse Sepsis studies →

Lead sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is the lead sponsor of 466 studies on the registry; 271 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A patient with neurogenic cystitis with sepsis and mental retardation.

Inclusion criteria

Dysgnosia Neurogenic bladder Pyohemia

Exclusion criteria

Exclusion Criteria:

Intellectually normal person No urinary infection

05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
1 participant (actual)
Patient registry
No

Interventions

  • Othernoting

    Non intervention

06

What researchers measure

Primary outcomes

  1. Lactic acid

    "In some pathological conditions, such as respiratory failure or circulatory failure, tissue hypoxia may be induced, and due to this hypoxia, lactic acid in the body may be elevated." Elevated lactic acid in the body can cause lactic acidosis. Checking the blood lactate level may indicate the severity of the underlying disease.The normal range is 0.05mmol/L-1.7mmol/L.

    Time frame: During the first 6 days of ICU stay

  2. Sequential Organ Failure Assessment

    This scale can describe the dysfunction or failure of individual organs in a continuous form, and can evaluate the degree of mild dysfunction to severe failure. It can be used to measure the occurrence and development of single or whole organ dysfunction repeatedly in clinical research, so as to determine the characteristics describing organ dysfunction or failure, which has a closer relationship with sepsis.

    Time frame: During the first 3 days of ICU stay

  3. Indicators of infection

    Hemameba level

    Time frame: During the first 6 days of ICU stay

  4. C-reaction protein

    Indicators of infection

    Time frame: During the first 6 days of ICU stay

07

Study locations

1 site
  • One Case of Individualized Nursing Plan for Sepsis
    Guangzhou, Guangdong 510220, China
08

References and documents

Publications

  • Yang PY, Meng NH, Chou EC. Voiding dysfunctions in children with mental retardation. Neurourol Urodyn. 2010 Sep;29(7):1272-5. doi: 10.1002/nau.20824. PubMed 19852064 ↗
  • Wehrberger C, Madersbacher S, Jungwirth S, Fischer P, Tragl KH. Lower urinary tract symptoms and urinary incontinence in a geriatric cohort - a population-based analysis. BJU Int. 2012 Nov;110(10):1516-21. doi: 10.1111/j.1464-410X.2012.11022.x. Epub 2012 Mar 12. PubMed 22409717 ↗
  • Dinh A, Hallouin-Bernard MC, Davido B, Lemaignen A, Bouchand F, Duran C, Even A, Denys P, Perrouin-Verbe B, Sotto A, Lavigne JP, Bruyere F, Grall N, Tavernier E, Bernard L. Weekly Sequential Antibioprophylaxis for Recurrent Urinary Tract Infections Among Patients With Neurogenic Bladder: A Randomized Controlled Trial. Clin Infect Dis. 2020 Dec 15;71(12):3128-3135. doi: 10.1093/cid/ciz1207. PubMed 31867616 ↗
  • von Gontard A, Hussong J, Yang SS, Chase J, Franco I, Wright A. Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability-A consensus document of the International Children's Continence Society. Neurourol Urodyn. 2022 Jan;41(1):102-114. doi: 10.1002/nau.24798. Epub 2021 Sep 29. PubMed 34586694 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05727293
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Responsible party
Sponsor
First posted
Feb 14, 2023
Start date
Sep 6, 2022
Primary completion
Oct 10, 2022
Completion
Nov 6, 2022
Last update
May 30, 2023

Study contacts

huiying Fuhuiying
principal investigator · colleague

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion